The core technology in MyGenostics is the highly-efficient DNA enrichment technique we developed. Our technology has the following advantages:
EffectivenessOur advanced and patented technologies enable us to efficiently enrich the DNA from several kbp up to 50Mbp or whole exome. The great evenness allows you to cover >98% of the targeted genome regions with minimum sequencing. In many cases, we can even get 100% of the targeted positions effectively sequenced. One more distinct advantage is that our technology can capture both sense and non-sense strand of the DNA molecule, which further enhances the enrichment efficiency.
Easy to UseOur solution based biotinylated DNA probes are more stable than RNA probes, no need to worry about degradation during the whole process. Simple hybridizing, binding, washing, elution steps will enable one technician to enrich 20 samples in 25 hours (20 hours hybridization, 5 hours bind, wash, etc). Our enrichment process is also compatible with current automation instruments, which enables you to do high-throughput enrichment.
Low PriceOne of the great advantages compared to our competitors is that the low cost of our technology enables us to offer the customer service at a very competitive price. With our service, any lab without any genomic sequencing experience can do target next-generation genomic sequencing at a very low cost. We can provide discount to institutional customers and additional discount to the bulky orders.
FlexibilityWe can enrich any part and any size of the genome. We launch the product and services covering the whole spectrum of next generation sequencing. We can provide target enrichment reagent kit alone or services covering from DNA library-making to enrichment service, sequencing service and bioinformatic analysis, which flexibly fit your need.
SensitivityOur technology was tested to work very well on FFPE samples and different clinical samples. With very deep sequencing, our technology enables you to detect as low as 0.5% mutations for all targeted positions in the biosamples.